Project Number 5R41AG062163-02 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Astrocyte activation by small-molecule ADORA3 agonists: a novel therapy for Alzheimers disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator LECHLEITER, JAMES D Principal Investigator First Name JAMES Principal Investigator Last Name LECHLEITER Awardee Organization ASTROCTYE PHARMACEUTICALS, INC. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-575: PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) FY Overall Cost $98,118 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
